Topiramate
Product Images NDC 50436-9952

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50436-9952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a graph titled "Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure". The graph compares the effects of two doses of Topiramate (50mg/day and 400mg/day) on patients who are at risk of developing seizures. The X-axis represents the time in days, while the Y-axis represents the percentage of patients who have not had a seizure at a given time. The graph shows that patients who took 400mg/day of Topiramate had a significantly lower risk of experiencing a seizure compared to those who took 50mg/day. The statistical significance of the results is indicated by the p-value of 0.0002.*
FDA Label Image

Label Image (Lbl504369952)

Label Image (Lbl504369952)
This appears to be a label for a medication called Topiramate, with 200 mg pills and 60 tablets per bottle. NDC (National Drug Code) number 50436-9952-2 is also provided. It also mentions an ADC (Automated Dispensing Cabinet) number 62756-0712-13, which most likely refers to its inventory management system. The rest of the text is not legible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.